Skip to main content

Tag: Portugal

Study Determines Best Practices For Cannabis Oil Production

Cannabis products and consumption methods come in many forms these days, with cannabis oil being a particularly popular one. Cannabis oil is versatile in several ways, not the least of which is its versatility from the perspective of international transportation.

Oil typically has a longer shelf life compared to raw flower and takes up much less space when being transported. At the most basic level, cannabis in oil form allows companies to ship far more cannabinoids to far-off destinations than if they were to ship raw flower to be processed at their final destination. That is an important factor for an industry that continues to go global.

Additionally, many governments seem to prefer cannabis oil products over other medical cannabis products for various reasons, as reflected by the rules and regulations currently in place in many legal medical cannabis markets. Patient testimonials highlight that cannabis oil is an effective form of consumption.

Earlier this week, SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines, in collaboration with Lusófona University, the largest Portuguese private university and the main institution of Grupo Lusófona, published a groundbreaking peer-reviewed paper titled “Process Development for GMP-Grade Full Extract Cannabis Oil: Towards Standardized Medicinal Use.”

Key findings from the collaborative study, which showcases the best practices for cannabis oil production, include:

  • Deep-cooled ethanol extraction and purification preserve the native cannabinoid and terpene profile of the plant throughout the production process
  • Improvements in taste, color, and overall appearance make these preparations more tolerable and effective for patients
  • Terpene fingerprint from the flower is remarkably preserved and can be controlled for reintroduction, emphasizing that terpene formulation is a science, not guesswork

“This paper underscores SOMAÍ’s scientific leadership in the cannabis pharmaceutical industry,” said Michael Sassano, Founder and Interim CEO of SOMAÍ. “Our study demonstrates that full-spectrum cannabis formulations can be scientifically structured, reproducible, and pharmaceutically precise—dispelling the misconception that full-spectrum must mean uncontrolled or inconsistent.”

“This research is a step forward in establishing scientific rigor within the medical cannabis field,” said Professor Maria do Céu Costa of Lusófona University. “Our findings show that with the right methodology, it is possible to preserve the integrity of the plant while achieving consistency, safety, and improved patient acceptance. It’s a meaningful contribution to both science and therapeutic innovation.”

“Unlike unrefined crude extracts or formulations created without standardized methodology, SOMAÍ’s approach is rooted in pharmaceutical science and controlled processes. This ensures a consistent cannabinoid and terpene profile that meets rigorous regulatory requirements while enhancing both the therapeutic efficacy and patient experience.” the company stated in a press release about their cannabis oil production.

A recent market analysis conducted by DataM Intelligence 4 Market Research LLP found that the “global hemp extracts market reached US$ 3.81 billion in 2024 and is expected to reach US$ 6.75 billion by 2032, growing with a CAGR of 7.41% during the forecast period 2025-2032.”

European Cannabis Reform Demonstrations Scheduled For May 31st

Cannabis activism comes in many forms. Working to modernize cannabis policies in any jurisdiction where prohibition is in place is not easy and requires a diversity of tactics. One of those tactics that activists have incorporated for decades is public demonstrations and protests.

Peaceful protests and demonstrations are necessary in jurisdictions where people in power refuse to be sensible about cannabis policy and reform discussions. When policymakers are committed to ignoring or gaslighting cannabis advocates when they call for sensible laws and regulations, it is time for the masses to take to the public spaces, have their voices heard, and remind society that the cannabis movement is large and passionate.

There are at least two demonstrations scheduled to take place on Saturday, May 31st, in Europe. The first is a demonstration in Rome, Italy. DolceVita describes the demonstration as (translated from Italian to English) “the demands against the Security decree join those of hemp in demonstration with the presence of the Million Marijuana March.”

“Thousands of people will descend on Piazza Vittorio to say no to the Security decree, which, among other things, risks wiping out the Italian industrial hemp sector with a single stroke.” DolceVita also reported. “The one organized by Rete No Ddl Sicurezza and Million Marijuana March is much more than a demonstration. But one of the last opportunities to try to stop a law that, if definitively approved, would decree the closure of over 3 thousand companies and the dismissal of over 22 thousand workers.”

“The reasons for this massive mobilization are rooted in deep concerns about what will happen to the country’s hemp sector. The issue is not only economic, but also social. Announced crackdown on hemp could lead to closure of thousands of legal businesses; it may result in job losses and a subsequent rise of the black market.” reports Soft Secrets about the upcoming demonstration in Rome.

“Italy’s government passed the new Decree Law on Citizen Security on April 4, 2025, promoted by the leading Fratelli d’Italia conservative right-wing party and Prime Minister, Giorgia Meloni. The measure imposes rigid restrictions that will severely impact Italy’s industrial hemp sector and CBD products – one of the biggest in Europe.” the outlet also wrote.

The second demonstration will be held in Lisbon, Portugal. The Lisbon demonstration is reportedly organized by the March for Cannabis Collective, and is scheduled to start at 15:30 pm at Jardim das Amoreiras. Attendees will be advocating for the full legalization and regulation of recreational, medical, and industrial cannabis use.

“The March for Cannabis will be taking place in the heart of Lisbon next Saturday, in an event that usually brings together a large part of society that advocates for a change in the framework of cannabis.” reports CannaReporter. “The event, scheduled for 15:30 pm, will be held at Jardim das Amoreiras. At 16:20 pm, the March will begin its route towards Largo de Camões, in a walk that unites activists, patients, hemp farmers and even tourists in a single voice calling for legislative change.”

Check with local activists and organizations in your area to see if any demonstrations are being planned in your region on May 31st, and as always, keep fighting for sensible cannabis policies and regulations where you live by educating policymakers and nonpolicymakers about the benefits of modernized cannabis policies and the harms of prohibition.

Portugal’s Cannabis Exports Have Nearly Tripled

The legal medical cannabis industry has experienced tremendous growth in recent years, particularly in Europe. One country that is witnessing substantial growth of its emerging medical cannabis industry is Portugal, where cannabis exports are booming.

“According to data provided to ECO by the National Authority for Medicines and Health Products (Infarmed), sales abroad totalled 32,558 kilos, covering cultivation, manufacturing and wholesale trade activities.” reported The Portugal News in its local coverage (translated to English).

“Germany, Spain, Poland, the United Kingdom and Australia were the top five destinations for medical cannabis exports last year. With this year-on-year growth of 172%, which made the volume exceed 65 tons in 2019, the country consolidated its status as the largest European exporter and second in the world, a ranking in which it appears behind only Canada.” the outlet also reported.

One factor that people should have on their radars is the rise of domestic medical cannabis production in major markets, particularly in Germany. As part of the nation’s 2024 CanG law, caps on domestic medical cannabis production were removed in Germany.

It will take time for domestic production to significantly ramp up in Germany, which is Europe’s largest legal medical cannabis market, but once it does, it could impact imports from other countries such as Portugal.

Cannabis is now legal in some form, whether it be for medical use, adult use, or in the form of industrial hemp, in over 115 countries. According to a recent study conducted by researchers from Ukraine and France, and published by the U.S. National Institute of Health, 57 countries have adopted medical cannabis legalization measures.

Attend CannaPortugal On May 19th And 20th

It is a truly historic era right now for cannabis policy, industry, and research, particularly on the European continent. Adult-use legalization is receiving significant attention in Europe right now, and understandably so. However, there’s currently far more going on with the continent’s emerging legal cannabis industry than just the push to legalize adult-use sales.

Europe’s legal medical cannabis industry continues to make strides at the national level, and ‘cannabis light’ is a sector of the industry that is growing in popularity. Products focused on hemp-derived CBD and lesser-known cannabinoids continue to enter the space as well.

All the while laws are being reformed, rules and regulations are being implemented, and consumer and patient trends continue to evolve. With so much going on in Europe’s cannabis industry, it can be difficult to keep up with the best and most timely information.

The CannaPortugal International Hemp and Cannabis Expo will take place on May 19th and 20th at the Centro de Congressos de Lisboa/Junqueira and we are encouraging people that are serious about the cannabis industry to consider attending. The event will bring hundreds of investors and specialists from more than a dozen countries together in a single space, in addition to featuring exhibitors and celebrities from the cannabis research and economic sectors.

“This is an event with established credits, in Lisbon, which aims to disseminate scientific knowledge, add value and accompany the expansion of the hemp sector, in particular, and cannabis, in general, as well as to reinforce the entire production process, without forgetting the positive impact that cannabis activity has in the field of human rights, quality of life, health, sustainability of the planet and economic development.” event organizers stated in a press release.

CannaPortugal integrates several initiatives, with a view to different professional areas and audiences. In addition to the Fair component of the event, with close to a hundred companies and national and international projects, the Expo integrates a B2B (business to business) program.

Additionally, CannaPortugal will feature professional workshops, to be carried out by specialist trainers in the area of ​​cannabis medicine, including:

  • Dr. Tanja Bagar, Slovenia
  • Dr. Neuza Fernandes, Brazil
  • Dr. Rafael Traldi, Brazil
  • Hugo Monteiro, Portugal
  • Chef Luís Pimenta, Portugal

CannaPortugal will also feature debates and round tables, with renowned national and international speakers, including:

  • Luna Stower, USA
  • Marcelo De Vita Grecco, Brazil
  • Del HendriXson, USA
  • João Taborda Gama, Portugal
  • Peter Homberg, Germany
  • Marcelo Demp, Paraguay
  • Elad Kaspin, Israel-Portugal
  • Maria Lourdes Serpa, USA
  • Giocomo Bulleri, Italy
  • Maren Krings, Germany
  • Sofia Fernandes, Portugal
  • Pedro Anastácio, Portugal
  • Bozidar Radisic, Slovenia
  • Carlos Beltrão, Spain
  • Neuza Fernandes, Brazil
  • Grant M. Saxena, USA
  • André Fajardo, Brazil
  • Eric Boone, USA
  • Francisco Almeida Ferraz, Portugal
  • Mila Jansen, Holand
  • Rita Oliveira, Portugal
  • Maurício Galvão, Brazil
  • Aimée- Aimée A. Drouin, USA
  • Carla Da Silva, Canada

The Expo also includes a wide range of innovative cultural activities, including the Global Cannabis Awards to honor personalities, countries, and projects that have contributed to the advancement of the cannabis industry around the globe.

Also, the event will include the HempAction Cannabis Fashion Show by GreenFits and Neuron Bonus with the participation of Weedog (Brazil) Cannabis Holistic Therapeutic Center. There will also be the Cannabis Art Space, a Media Center for the media and influencers, the Enthronement of the Confraria Internacional Cannabis Portugal, a Car Exhibition with hemp components, a Cannabis Food and Drinks Court, as well as music by Carlota Barros, vocalist of Telefonia.

CannaPortugal will be open on May 19th and 20th from 10am to 8pm. On May 21st, CannaPortugal participants and visitors will be offered a special tour of the capital – “Lisbon Cannabis Historical Tour” – which aims to explore the relationship between Portugal and the traditional cultivation of hemp in the country.

You can find out more about CannaPortugal and purchase tickets at: https://cannaportugal.com

Here Comes Portugal: Adult Use Bill Brought Before Parliament

Cannabis reform is not staying still across the EU

As Europe begins to wake up to the reality that two countries within and just outside its border (Luxembourg and Switzerland) are about to give the region its “Colorado and Washington State” moment – Portugal appears to want to up the ante even more.

In a move highly anticipated by insiders, and just before a summer of intermittent travel corridors and mutating summer holiday plans along with new variants of Covid, the Portuguese also seem determined to have their moment in the sun.

However, the Portuguese situation is also not likely to be like any of the other discussions going on in Europe at the moment. This starts with the fact that the government has been playing with the idea of drug liberalization and lassaiz faire drug reform for the last fifty years in a way unseen in any other European state.

The timing of this discussion – literally to carve out and define a national policy on adult-use – is also far from accidental.

This development means that three countries within Europe (the other two are Holland and Luxembourg) plus Switzerland are now formally debating if not implementing adult-use market guidelines and policies.

This is a tipping point. Even if the German government (for one) along with the French and Spanish, would rather ignore the entire enchilada.

Where Does This Leave Germany?

There is much speculation within the country if not beyond its borders about the impact of the national election this year on cannabis normalization. That said, while it is likely that the political winds are likely to elicit some reform (see perhaps decriminalization) it is unlikely that full boat recreational use will be on the table here for the next five years.

In the meantime, experimental and feeder markets (Greece, Malta, North Macedonia) beyond these recreational outliers, are clearly beginning to define medical cultivation markets that will feed tax coffers and create green jobs. At some point, there will be a Deutsch tipping point. The question, of course, is what might cause this. And when it might come.

Medical markets will only continue to push the topic forward – and of course bigger economic issues – like Post Pandemic recovery – will also feed into the debate.

Regardless, for advocates and the industry alike, the summer of 2021 is turning out to be a good one for pushing the theoretical idea of reform forward, if not exactly the mechanics, in countries across the region like never before.

Be sure to book your tickets to the International Cannabis Business Conference when it returns to Berlin this August!

Portuguese Authorities Set Retail Price For Medical Cannabis

Infarmed, the Portuguese medicines and medical devices agency, has now set a reference retail price for medical cannabis patients in pharmacies that equals the black-market price – but still no word on whether health insurers will reimburse the costs.

Portuguese patients can look forward to a more regulated retail price for medical cannabis at pharmacies as of April this year. Infarmed, the Portuguese version of the FDA, has set the price for 15-gram bags of medical cannabis at the point of sale in pharmacies at €150 per bag of 18% THC flower. This means that retail prices for cannabis in pharmacies is now set at widely set black market rates across Europe.

This price point is also roughly equivalent to what insurers are reimbursing pharmacies for in Germany – which begins to create a regional, not just in-country reference price for the industry.

The next problem is, however, is that unlike Germany, the list of conditions the drug will be prescribed for is much narrower than in Deutschland (basically six conditions commonly seen in MS, cancer, AIDS and chronic pain). Further, there is no discussion (yet) as to whether national health will cover the cost (as is true in Germany, even if it is still a major bureaucratic, paper strewn fight). In Germany, those patients who are able to obtain coverage face a bill of €12 a month.

How Will This Help the Overall Legalization Discussion?

While the formal price setting is certainly a good step, and further one which takes real market conditions into consideration, a terrible price gap is still in the room for the most vulnerable of patients – in other words, precisely the people who are likely to get a prescription in the first place. Three hundred euros a month is about the amount of disposable cash a person on disability benefits gets to spend every month on food and other essentials. There is no way such people can afford the new “legal” channel of cannabis unless they get some kind of additional help.

Regardless of the immediate impact on the ground in Portugal however, this is a clear sign that the commercial medical market is in fact beginning to normalize – not only in country but across the region.

This also means that GMP producers, for example, can begin to have a much clearer idea of returns, costs and margin throughout the supply chain. This in turn will have a stabilizing impact on the industry – and allow investors to have a much better idea of potential returns.

As a result? 2021 and beyond should begin to see the kind of serious investment in the infrastructure of the industry that it actually needs. And that is good news for everyone.

Be sure to book your tickets now for the upcoming investment and business networking International Cannabis Business Conference in Austin and Berlin!

Portugal Moves Forward On Regulating Domestic Hemp Market

On August 4, the Portuguese government issued a regulatory document that authorizes the cultivation and exploitation of the domestic hemp market.

According to the document, translated from Portuguese, the law “establishes the conditions, authorizations and inspection that apply to the cultivation, production, manufacture, employment, trade, distribution, import, export, introduction, dispatch, transit, possession for any purpose and use of plants, substances and preparations.”

Here are the big takeaways:

  • The Departments of Agriculture and Justice have an overview and supervisory authority over the vertical for hemp bound for industrial purposes. The Institute for the Financing of Agriculture and Fisheries along with the Judiciary Police, National Republica Guard and the Public Security police will also all have a role to play in the regulation and oversight of the industry and its regulatory schemata and rules.
  • Regardless, however, no matter where the hemp is grown, it will be subject to certification just because of difficulty authorities have already identified, namely understanding quickly which plant is which (higher THC cultivars vs. low THC plants with less than 0.2%).
  • This classification includes all hemp grown for non-human consumption (i.e. industrial) and animal food.
  • The regulations will also be applied to the medical cannabis market – namely creating a space domestically for the legal prescription of narcotic drugs.
  • Sets fees for cultivation (3,000), additional certifications (1,000), and additional charges set by the government for the licensing and certification process.

Significance In the European Market

Portugal is currently one of the few countries which have allowed cannabis production from the medical perspective since Tilray established production facilities in the country in 2017. Now, however, it is clearly joining the list of European countries determined to try to regulate hemp separately.

This means, however, that the country has not taken a stand on the discussion before any European Commission decision that hemp is somehow a “narcotic” (pending in September). The Portuguese decree also does not appear to take a stand on the question of whether hemp is “novel” or not for human consumption.

This careful designation, in other words, appears to presage a future where the terms and conditions of the entire industry are set by those who believe that hemp or its extracts are somehow “new” in Europe. Or potentially classified for all human consumption as a “narcotic.”

In the meantime, beyond the headlines, German-produced, and EU-BIO certified, higher quality hemp oil is showing up in chain grocery stores across Deutschland.

It is inevitable that there are a few rounds left in the entire discussion from the regional and country perspective.

In the meantime, another country in Europe has established a formal hemp program, even if it seems to be a very small first step.

Join the International Cannabis Business Conference when it returns to Europe in 2021. Until then, stay tuned to our blog!

What Is Going On With Portugal’s Cannabis Industry?

Licensing is underway in Portugal, although the competition is as fierce as it is in many other markets. The government changes rules, slowly, then opens up the gates and then everyone rushes (or tries to rush in).

The interesting thing about Portugal right now from an international perspective (certainly in Europe) is how the country is starting to pivot to cannabis production that is licensed, medical, and bound for export.

But how will freewheeling, “all drugs are decriminalized” Portugal really stack up against other contenders moving into this space, such as Spain, Greece, Poland and (North) Macedonia? They all have great weather, cheap labour rates (or at least cheaper than Germany and the UK), and are closer to Europe than Canada, Latin America, or Africa.

Is freewheeling Portugal really all its cracked up to be? Not really, and politically the current temperature is bound for a backlash. It is one thing to decriminalize all drugs. It is another thing to deal with those who use them irresponsibly.

And then there is this – between 2012 and 2017, statistics for alcohol, tobacco, and drug use in the general population have actually risen 23%. There has been just under a 2% increase in the use of psychoactive drugs in the same period.

While this could also be traced to the economic meltdown that hit many less prosperous countries in Europe hard during that time period, it is not a great PR moment for the canna cause.

Further, Portugal is not entirely copacetic on the idea of actually legalizing medical or recreational cannabis use (including grow your own). It hasn’t really happened yet.

Democratizing The Weed

No matter the impressive stats that the industry is starting to chalk up, there is far from democratic access to the plant, and that exists almost nowhere, even when governments are responsible for sales (as is the case in Europe).

How should the involved parties proceed? Everyone needs to get paid.

Many of these issues, in truth, will continue to evolve. In the future, assuming there is a survival of government health care, expect these themes to belong in the room. How much money medical cannabis can actually save health insurers is still a conversation for the future. However, conversations like this will not occur in an environment where the plant and products created from it are seen as “expensive.”

The Portuguese experiment is an intriguing situation that has already begun to impact the discussion across the continent, and will for a long time to come. Going forward it is clear that even the relatively freewheeling country of Portugal is starting to look at the entire discussion with a bit more of a conservative viewpoint.